EUVIMEDEUVIMED entdecken
Crossref

Is advanced age still a risk factor for recurrence of C. difficile infection in the era of new treatments?

Cecilia Suárez-Carantoña iD, María Dolores Corbacho-Loarte, Laura Del Campo Albendea, Sara Kamel-Rey, Ana Verónica Halperin, Rosa Escudero-Sánchez, Manuel Ponce-Alonso, Santiago Moreno, Javier Cobo

Age and Ageing · 2024

DOI: 10.1093/ageing/afae182 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Age and Ageing, 2024. Verfasst von Cecilia Suárez-Carantoña und 8 weiteren Autor:innen. Beteiligte Einrichtung: Internal Medicine Department, Hospital Ramón y Cajal, IRYCIS, Madrid, Spain. Hauptthemen laut MEDLINE: Clostridium Infections, Recurrence. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 29 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Advanced age has been widely identified as a risk factor for recurrent Clostridioides difficile infection (CDI), but most related studies were performed before the introduction of novel therapies. The aim of this study was to compare CDI characteristics and outcomes in patients over and under 80 years old with CDI and their outcomes in the era of new treatments.

Methods

This was a retrospective cohort study of patients diagnosed with CDI from January 2021 to December 2022 in an academic hospital. We compared recurrence and mortality at 12 weeks after the end of treatment. An extension of the Fine and Grey model adjusted for competing events was used to assess the effect of age on recurrence.

Results

Four hundred seventy-six patients were considered to have CDI (320 in patients <80 years and 156 in ≥80 years). CDI in older patients was more frequently healthcare-associated and was more severe. Although the Charlson index was almost identical between populations, comorbidities clearly differed. New treatments (bezlotoxumab, fidaxomicin and faecal microbiota transplantation) were more frequently used in older patients without statistical significance (41.3% vs. 33.4%, P = .053). There were 69 (14.5%) recurrences, with no differences by age group after adjusting for competing events. Mortality was greater in the oldest (35.3%) than in the youngest (13.1%); P < .001.

Conclusions

No differences in CDI recurrence rates were found between age groups. However, there was a high mortality rate in patients ≥80 years old, which emphasises the urgent need to improve the prevention and treatment of CDI in this group.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Clostridium InfectionsRecurrenceHumansMaleAged, 80 and overFemaleRetrospective StudiesRisk FactorsAgedAge FactorsFecal Microbiota TransplantationAnti-Bacterial AgentsClostridioides difficileMiddle AgedFidaxomicinBroadly Neutralizing AntibodiesAntibodies, Monoclonal

Stichwörter der Autor:innen

Clostridioides difficileinfectionolder people

Substanzen

Anti-Bacterial AgentsbezlotoxumabFidaxomicinBroadly Neutralizing AntibodiesAntibodies, Monoclonal

Autor:innen und Institutionen

  • Internal Medicine Department, Hospital Ramón y Cajal, IRYCIS, Madrid, Spain.
  • Faculty of Medicine and Health Sciences, Alcalá University, Madrid, Spain.
  • Infectious Diseases Department, Hospital Ramón y Cajal, IRYCIS, Madrid, Spain.
  • CIBER de Enfermedades Infecciosas, Instituto de Salud Carlos III, Madrid, Spain.
  • Biostatistics Department, Hospital Ramón y Cajal, IRYCIS, Madrid, Spain.
  • CIBER de Epidemiologia y Salud Pública, Instituto de Salud Carlos III, Madrid, Spain.

ORCID-Profile: Cecilia Suárez-Carantoña

Zitieren

APA

Suárez-Carantoña, C., Corbacho-Loarte, M. D., Del Campo Albendea, L., Kamel-Rey, S., Halperin, A. V., Escudero-Sánchez, R., Ponce-Alonso, M., Moreno, S., & Cobo, J. (2024). Is advanced age still a risk factor for recurrence of C. difficile infection in the era of new treatments?. Age and Ageing. https://doi.org/10.1093/ageing/afae182

Vancouver

Suárez-Carantoña C, Corbacho-Loarte MD, Del Campo Albendea L, Kamel-Rey S, Halperin AV, Escudero-Sánchez R, et al. Is advanced age still a risk factor for recurrence of C. difficile infection in the era of new treatments?. Age and Ageing. 2024. doi:10.1093/ageing/afae182

BibTeX
@article{SurezCarantoa2024,
  author = {Suárez-Carantoña, Cecilia and Corbacho-Loarte, María Dolores and Del Campo Albendea, Laura and Kamel-Rey, Sara and Halperin, Ana Verónica and Escudero-Sánchez, Rosa and Ponce-Alonso, Manuel and Moreno, Santiago and Cobo, Javier},
  title = {Is advanced age still a risk factor for recurrence of C. difficile infection in the era of new treatments?},
  journal = {Age and Ageing},
  year = {2024},
  doi = {10.1093/ageing/afae182}
}
Kostenlos starten →